A Nitrilium-Type <i>N</i> -Heterocyclic Aryne
The first solution-phase synthesis and reactivity of a nitrilium-type <i>N</i>-hetaryne are described. The 1,2-azaborine-derived 1,6-BN-aryne <b>2</b> exhibits [4 + 2], [3 + 2], and [2 + 2] cycloadditions and electrophilic aromatic substitution (EAS) reactivity. The observed regio- and diastereoselectivities of the cycloaddition and EAS products are consistent with a polarized aryne/nitrilium species. The free 1,6-BN-aryne <b>2</b> was isolated and characterized under matrix isolation conditions. A Lewis structure description where the 1,6-BN-aryne <b>2</b> resonates between two limiting (ketenimine (dominant) vs nitrilium) forms is consistent with DFT calculations. New 1,2-azaborine structures that are functionalized at the C6- and N-positions, including highly strained derivatives that were previously not accessible, can now be accessed using 1,6-BN-aryne <b>2</b> as a versatile synthetic building block.
Authors
- Hugues Preud’homme (ORCID: https://orcid.org/0000-0003-3756-6190)
- Marisol Sarmiento Alvarado
- Holger F. Bettinger (ORCID: https://orcid.org/0000-0001-5223-662X)
- Christina Tönshoff
- Clovis Darrigan (ORCID: https://orcid.org/0000-0001-5197-8293)
- Lauren My-Linh Tran (ORCID: https://orcid.org/0000-0001-7554-676X)
- Shih‐Yuan Liu (ORCID: https://orcid.org/0000-0003-3148-9147)
- Anna Chrostowska (ORCID: https://orcid.org/0000-0003-0371-4546)
- Bo Li
Institutions
- Boston College (US)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Université de Pau et des Pays de l'Adour (FR)
- Institut des Sciences Analytiques et de Physico-Chimie pour l'Environnement et les Matériaux (FR)
- University of Tübingen (DE)
Publication Details
- Journal
- Journal of the American Chemical Society
- Published
- 2025-06-02
- DOI
- https://doi.org/10.1021/jacs.5c05146
- Citations
- 1
- Primary Topic
- Cyclization and Aryne Chemistry
- Type
- article
- Field-Weighted Citation Impact
- 0.94
Funders
- Université de Pau et des Pays de l'Adour
- National Institute of General Medical Sciences